What the cancer clinician and researcher need to know
The increasing integration of machine learning into the clinical and research landscapes of blood cancers merits understanding and attention from unfamiliar researchers and clinicians alike, according to a review recently published in Lancet Haematology. Senior author and Director of Cleveland Clinic’s Center for Clinical Artificial Intelligence Aziz Nazha, MD worked with a team to develop a computer model for prognostication for acute myeloid leukemia patients with more algorithms under development. He and his coauthors present in the Lancet article an overview of key terminology and current concepts pertinent to any clinician. Read the article here.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention
Global R&D efforts expanding first-line and relapse therapy options for patients
A case study on the value of access to novel therapies through clinical trials
Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients
Cleveland Clinic oncologists’ selected abstracts
On-demand stem cell mobilizer is an effective salvage strategy
Dispelling myths and sharing practical experiences
Research indicates strong rationale for expanding trial eligibility criteria